Latest news and press releases about NRC Health (NRC): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences.
Price
| Price | $22.05 |
| Market Cap | $497M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 84.00 |
| Price / Book | 74.10 |
| EV / EBITDA | 24.03 |
| Dividend Yield | 2.72% |
Profitability
| Return on Equity | 48.46% |
| Return on Invested Capital | 8.75% |
| Return on Assets | 4.30% |
| Gross Margin | 66.79% |
| Operating Margin | 10.53% |
| Net Margin | 4.18% |
Related companies: DH · HCAT · NNOX · PBYI · QTRX · SNWV · SOPH
Explore sector: Healthcare · Medical - Healthcare Information Services
More sections of NRC: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks